FDA approves Sorilux for scalp psoriasis

The Food and Drug Administration has approved Sorilux Foam 0.005 percent for the topical treatment of plaque psoriasis of the scalp. » More

Share »

Students ID more cancers with dermoscopy training

Medical students can better identify and diagnose skin cancer after learning how to use a dermatoscope, researchers have found. » More

Share »

Resource Center: Melanoma: Advances in Diagnosis & Therapy

A devastating disease with a rising incidence, melanoma kills 1 person every hour in the United States. Find our dermatology diagnosis tool, articles on advances in diagnosis and therapies, and CME here assist you in meeting the significant healthcare burden of melanoma.

fyi...

73%

Percentage of patients with psoriasis who say the condition has a moderate to high impact on their lives

Source: 21st EADV Congress

Resource Center: Eczema: Emollients, Counseling, and Care

Folic Acid Supplements Up Risk of Eczema.

Biologics linked to lower CV disease rates

Patients with severe psoriasis who were treated systemically with biologic agents or methotrexate had a lower combined risk of death, myocardial infarction and stroke, according to the results of a recent study. » More

Share »

Filler boosts infection risk in HIV patients

The use of polyalkylimide filler in patients with HIV-related facial lipoatrophy is associated with a high risk of infectious complications, which can occur years after treatment, according to a recent study. » More

Share »